Lipoprotein X Causes Renal Disease in LCAT Deficiency

• Alice Ossoli ,

  Contributed equally to this work with: Alice Ossoli, Edward B. Neufeld

  Affiliation Centro Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milano, Italy

  ⨯
• Edward B. Neufeld ,

  Contributed equally to this work with: Alice Ossoli, Edward B. Neufeld

  * E-mail: neufelde@mail.nih.gov

  Affiliation Lipoprotein Metabolism Section, Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Seth G. Thacker,

  Affiliation Lipoprotein Metabolism Section, Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Boris Vaisman,

  Affiliation Lipoprotein Metabolism Section, Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Milton Pryor,

  Affiliation Lipoprotein Metabolism Section, Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Lita A. Freeman,

  Affiliation Lipoprotein Metabolism Section, Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Christine A. Brantner,

  Affiliation NHLBI Electron Microscopy Core Facility, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Irina Baranova,

  Affiliation Clinical Center, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Nicolás O. Francone,

  Affiliation Lipoprotein Metabolism Section, Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Stephen J. Demosky Jr.,

  Affiliation Lipoprotein Metabolism Section, Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Cecilia Vitali,

  Affiliation Centro Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milano, Italy

  ⨯
• Monica Locatelli,

  Affiliation IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy

  ⨯
• Mauro Abbate,

  Affiliation IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy

  ⨯
• Carlamaria Zoja,

  Affiliation IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy

  ⨯
• Guido Franceschini,

  Affiliation Centro Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milano, Italy

  ⨯
• Laura Calabresi,

  Affiliation Centro Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milano, Italy

  ⨯
•  [ ... ],
• Alan T. Remaley

  Affiliation Lipoprotein Metabolism Section, Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• [ view all ]
• [ view less ]